Journal of Infection
Volume 54, Issue 2 , Pages e55-e57 , February 2007

Atypical cutaneous manifestation of HSV-2 with Candida albicans co-infection in a patient with HIV-1

,Accepted 29 March 2006.

References 

  1. Aloi F, Solaroli C, Papotti M. Perianal cytomegalovirus ulcer in an HIV-infected patient. Dermatology. 1996;192:81–83
  2. Denis BJ, May T, Bigard M-A, Canton P. Lesions anales et peri-anales au cours des infections symptomatiques par le VIH. Etude prospective d'une serie de 190 patients. Gastroenterol Clin Biol. 1992;16:148–154
  3. Schmitt SL, Wexner SD, Nogueras JJ, Jagelman DG. Is aggressive management of perianal ulcers in homosexual HIV-seropositive men justified?. Dis Colon Rectum. 1993;36:240–246
  4. Siegal FP, Lopez C, Hammer GS, Brown AE, Kornfeld SJ, Gold J. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med. 1981;305:1439–1444
  5. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med. 1995;333:770–775
  6. do Nascimento MC, Sumita LM, de Souza VA, Pannuti CS. Detection and direct typing of herpes simplex virus in perianal ulcers of patients with AIDS by PCR. J Clin Microbiol. 1998 Mar;36(3):848–849
  7. Mwansasu A, Mwakagile D, Haarr L, Langeland N. Detection of HSV-2 in genital ulcers from STD patients in Dares Salaam, Tanzania. J Clin Virol. 2002 Apr;24(3):183–192
  8. Langeland N, Haarr L, Mhalu F. Prevalence of HSV-2 antibodies among STD clinic patients in Tanzania. Int J STD AIDS. 1998;9:104–107
  9. Obasi A, Mosha F, Quigley M, Sekirassa Z, Gibbs T, Mungiti K, et al. Antibody to herpes simplex virus type 2 as a marker of sexual risk behaviour in rural Tanzania. J Infect Dis. 1999;179:16–24
  10. Bogaerts J, Ricart CA, VanDyck E, Piot P. The etiology of genital ulceration in Rwanda. Sex Transm Dis. 1989;16:123–126
  11. Tien PC, Kovacs A, Bacchetti P, French AL, Augenbraun M, Cole SR, et al. Association between syphilis, antibodies to herpes simplex virus type 2, and recreational drug use and hepatitis B virus infection in the Women's Interagency HIV Study. Clin Infect Dis. 2004 Nov 1;39(9):1363–1370
  12. Royce R, Sena A, Cates W, Cohen M. Sexual transmission of HIV-1. N Engl J Med. 1997;336:1072–1078
  13. Morse SA, Trees DL, Htun Y, Radebe F, Orle KA, Dangor Y, et al. Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection. J Infect Dis. 1997;175:583–589
  14. Behets FMT, Brathwaite AR, Hylton-Kong T, Chen CY, Hoffman I, Weiss JB, et al. Genital ulcers: etiology, clinical diagnosis, and associated human immunodeficiency virus infection in Kingston, Jamaica. Clin Infect Dis. 1999;28:1086–1090
  15. Stewart JA, Reef SE, Pellett PE, Corey L, Whitley RJ. Herpesvirus infections in persons infected with human immunodeficiency virus. Clin Infect Dis. 1995;21(Suppl. 1):S114–S120
  16. Augenbraun M, Feldman J, Chirgwin K, Zenilman J, Clarke L, DeHovitz J, et al. Increased genital shedding of herpes simplex type 2 in HIV-seropositive women. Ann Intern Med. 1995;123:845–847
  17. Koelle DM, Abbo H, Peck A, Ziegweid K, Corey L. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions. J Infect Dis. 1994;169:956–961
  18. Schacker T. The role of HSV in the transmission and progression of HIV. Herpes. 2001 Jul;8(2):46–49
  19. Mole L, Ripich S, Margolis D, Holodniy M. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis. 1997;176:766–770
  20. Schacker T, Shaughnessy M, Barnum G, Selke S, Corey L. Changes in HIV viral load during clinical episodes of HSV [abstract]. In: 33rd International Conference on Antimicrobial Agents and Chemotherapy (ICCAC), San Francisco, CA, USA; 1995.
  21. Heng MC, Heng SY, Allen SG. Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1. Lancet. 1994;343:255–258
  22. White MH. Is vulvovaginal candidiasis an AIDS-related illness?. Clin Infect Dis. 1996;22:124–127
  23. Cohn SE, Clark RA. Sexually transmitted diseases, HIV and AIDS in women. Med Clin North Am. 2003;87:71–75
  24. Ohmit SE, Sobel JD, Schuman P, Duerr A, Mayer K, Rompalo A, et al. HIV Epidemiology Research Study (HERS) Group. Longitudinal study of mucosal Candida species colonization and Candidiasis among human immunodeficiency virus (HIV) seropositive and at risk HIV-seronegative women. J Infect Dis. 2003;188:118–127
  25. Duerr A, Heilig CM, Meikle SF, Cu-Uvin S, Klein RS, Rompalo A, et al. HERS study group. Incident and persistent vulvovaginal Candidiasis among human immunodeficiency virus-infected women: risk factor and severity. Obstet Gynecol. 2003;101:548–556
  26. De Bernardis F, Mondello F, Scaravelli G, Pachi A, Girolamo A, Agatensi L, et al. High aspartyl proteinase production and vaginitis in human immunodeficiency virus-infected women. J Clin Microbiol. 1999;37:1376–1380
  27. De Bernardis F, Chiani P, Ciccozzi M, Pellegrini G, Ceddia T, D'Offizzi G, et al. Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolated from oral cavities of subjects infected with human immunodeficiency virus. Infect Immun. 1996;64:466–471
  28. Ollert MW, Wende C, Gurlich M, Macmullan-Vogel CG, Borg-von Zepelin M, Vogel C, et al. Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J Clin Microbiol. 1995;33:2543–2549
  29. Wu T, Samaranayake LP, Cao BY, Wang J. In vitro proteinase production by oral Candida albicans isolates from individuals with or without HIV infection and its attenuation by antimycotic agents. J Med Microbiol. 1996;44:331–336
  30. Staib P, Kretschmar M, Nichterlein T, Kohler G, Michel S, Hof H, et al. Host-induced, stage specific virulence gene activation in Candida albicans during infection. Mol Microbiol. 1999;32:533–546
  31. McDonald F. Secretion of inducible proteinase by pathogenic Candida species. J Med Vet Mycol. 1984;22:79–82
  32. Kaminishi H, Miyaguchi H, Tamaki T, Suenaga N, Hisamatsu M, Mihashi I, et al. Degradation of humoral host defence by Candida albicans proteinase. Infect Immun. 1995;63:984–988
  33. Ruchel R. Cleavage of immunoglobulins by pathogenic yeasts of the genus Candida. Microbiol Sci. 1986;3:316–319
  34. Ray TL, Payne CD. Scanning electron microscopy of epidermal adherence and cavitation in murine candidiasis: a role for Candida acid proteinase. Infect Immun. 1988;56:1942–1949
  35. Colina A, Aumont F, Deslauriers N, Belhumeur P, De Repentigny L. Evidence for degradation gastrointestinal mucin by Candida albicans secretory aspartyl proteinase. Infect Immun. 1996;64:4514–4519

PII: S0163-4453(06)00137-X

doi: 10.1016/j.jinf.2006.03.036

Journal of Infection
Volume 54, Issue 2 , Pages e55-e57 , February 2007

Article Tools

* Image Usage & Resolution